Total results651
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| GBRA2 | P47869 | Gamma-aminobutyric acid receptor subunit alpha-2 (GABA(A) receptor subunit alpha-2) (GABAAR subunit alpha-2) | 4 | General pain disorderIndeterminate colitisIntentional self-harm | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.53 | |||
| GBRA3 | P34903 | Gamma-aminobutyric acid receptor subunit alpha-3 (GABA(A) receptor subunit alpha-3) (GABAAR subunit alpha-3) | FDA approved drug targetsPredicted membrane proteinsTransporters | 4 | EpilepsyAnxiety disorderIndeterminate colitis | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.53 | ||
| GBRA5 | P31644 | Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A) receptor subunit alpha-5) (GABAAR subunit alpha-5) | 4 | Adaptive immunity immunodeficiencyAlzheimer diseaseAutism spectrum disorder | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.53 | |||
| GBRG3 | Q99928 | Gamma-aminobutyric acid receptor subunit gamma-3 (GABA(A) receptor subunit gamma-3) (GABAAR subunit gamma-3) | FDA approved drug targetsPredicted intracellular proteinsPredicted membrane proteins | 4 | Alzheimer diseaseAnxiety disorderCorneal disease | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.53 | ||
| GHR | P10912 | Growth hormone receptor (GH receptor) (Somatotropin receptor) [Cleaved into: Growth hormone-binding protein (GH-binding protein) (GHBP) (Serum-binding protein)] | Disease related genesFDA approved drug targetsHuman disease related genes | 1 | DwarfismCOVID-19Malaria | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.53 | ||
| GLP1R | P43220 | Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) | 7 | Acute diabetic complicationAlzheimer diseaseCardiovascular disease | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.53 | |||
| GLP2R | O95838 | Glucagon-like peptide 2 receptor (GLP-2 receptor) (GLP-2-R) (GLP-2R) | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins | 7 | Bowel habit changeDigestive system diseaseIndeterminate colitis | Clinical-translation mediationReceptor-signaling mediation | 1 | 0.53 | ||
| GLRA2 | P23416 | Glycine receptor subunit alpha-2 | Disease related genesFDA approved drug targetsPredicted membrane proteins | 4 | Intellectual disability | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.53 | ||
| GLT11 | Q8NCW6 | Polypeptide N-acetylgalactosaminyltransferase 11 (EC 2.4.1.41) (Polypeptide GalNAc transferase 11) (GalNAc-T11) (pp-GaNTase 11) (Protein-UDP acetylgalactosaminyltransferase 11) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11) | Disease related genesEnzymesMetabolic proteins | 1 | Heterotaxy | Metabolism mediation | 1 | 0.53 | ||
| GNAS3 | O95467 | Neuroendocrine secretory protein 55 (NESP55) [Cleaved into: LHAL tetrapeptide; GPIPIRRH peptide] | Cancer-related genesDisease related genesHuman disease related genes | Cushing syndromeDwarfismObesity | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.53 |